[144] Teradyne, Inc. SEC Filing

Rhea-AI Filing Summary

Teradyne's Form 144 reports a proposed sale of 554 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $58,724 and an approximate sale date of 08/12/2025 on NASDAQ. The filing lists total shares outstanding as 159,073,532, indicating the position is very small relative to the company's capitalization. The securities were acquired by restricted stock vesting on 01/27/2025, and the consideration is recorded as compensation.

The notice also records a prior sale of the same 554 shares on 07/30/2025 for $58,574.42. The form includes the standard Rule 144 representation regarding absence of undisclosed material adverse information and a field for Rule 10b5-1 plan adoption if applicable, though no plan adoption date is provided in the filing.

Insights

Securities Analyst

TL;DR: Small, routine insider sale of vested shares; immaterial to capitalization and unlikely to move markets.

The filing documents a proposed sale of 554 shares versus 159.07 million shares outstanding, representing a negligible proportion of the float. The shares were acquired via restricted stock vesting on 01/27/2025 and listed for proposed sale on 08/12/2025, with a prior sale of the same quantity on 07/30/2025 for $58,574.42. From a market-impact perspective this is de minimis; from a disclosure perspective it complies with Rule 144 requirements and signals monetization of compensation rather than a material change in insider holdings.

Corporate Governance Expert

TL;DR: Form 144 shows standard compliance; no governance red flags evident from provided details.

The document includes the required attestation about absence of undisclosed material adverse information and provides acquisition and payment details (restricted stock vesting; payment as compensation). No 10b5-1 plan adoption date is shown. Given the small size of the reported transactions and the clear characterization as vested compensation, the filing does not, on its face, raise governance concerns or indicate withholding of material information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	554	58724.00	159073532	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2025	Restricted Stock Vesting	Issuer			554	01/27/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gregory S. Smith 600 Riverpark Drive North Reading MA 01864	Common	07/30/2025	554	58574.42

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Teradyne (TER) report in this Form 144?

Teradyne's Form 144 reports a proposed sale of 554 shares of common stock with an aggregate market value of $58,724 and an approximate sale date of 08/12/2025.

Who is the seller named in the filing for TER?

The filing identifies the seller as Gregory S. Smith. No additional personal contact details are summarized here.

How were the shares being sold acquired?

The 554 shares were acquired by restricted stock vesting on 01/27/2025, and the nature of payment is listed as compensation.

Has the filer sold any TER shares in the past three months?

Yes. The filing records a sale of 554 shares on 07/30/2025 for gross proceeds of $58,574.42.

Which broker and exchange are listed for the proposed TER sale?

Broker: Fidelity Brokerage Services LLC. Exchange: NASDAQ.

Does the Form 144 indicate a Rule 10b5-1 plan was used?

No plan adoption date is provided in the filing. The form includes a field for plan adoption or instruction date if relying on Rule 10b5-1, but that date is not filled in.